Joe-Elie Salem
Prof Joe-Elie Salem is an expert in Cardiology at Pitié-Salpêtrière Hospital (France). As of October 2026, ScienceLeadR ranks Joe-Elie Salem in the top 1% of experts worldwide for Myocarditis, Cardiotoxicity and Cardiomyopathies. Joe-Elie Salem has authored 323 publications, the most recent in 2026, and is an investigator in 40 clinical trials, 8 of them ongoing. SLR score: 2,386 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Pharmacy - Oncology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2012 - 2026
Number : 323
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Response by Munir et al to Letter Regarding Article, "CXCR6 + T Cells Drive Immune Checkpoint Inhibitor Myocarditis". PMID 42862910 — cells, immune checkpoint inhibitors, myocarditis, blood circulation | Circulation Top journal | 2026 | 0 |
| COVID-19 vaccination around immune checkpoint inhibitor start and survival in a nationwide cohort of patients with cancer. PMID 42722885 — mortality, vaccines, molecular biology, neoplasms, vaccination, immune checkpoint inhibitors, covid-19, therapeutics | Nat Med Top journal | 2026 | 0 |
| Granulomatous Mimic of Immune Checkpoint Inhibitor Myocarditis. PMID 42723626 — granuloma, adrenal insufficiency, sarcoidosis, biomarkers, immune checkpoint inhibitors, diagnostic imaging, myocarditis | Circ Cardiovasc Imaging | 2026 | 0 |
| Immune Checkpoint Inhibitor Myocarditis and Myotoxicity. PMID 42709038 — troponin, cardiovascular system, signs and symptoms, immune checkpoint inhibitors, myocarditis, abatacept, pharmacology, myositis, myotoxicity, therapeutics, blood circulation | Circulation Top journal | 2026 | 1 |
| Rechallenge After Immune Checkpoint Inhibitors Myocarditis: Evidence and a Practical Framework: JACC Cardio-Oncology Primer. PMID 42319342 — biomarkers, immunotherapy, immune checkpoint inhibitors, myocarditis, cardiotoxicity, cardio-oncology | JACC CardioOncol | 2026 | 0 |
Clinical Studies 40
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
8 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| ATROPOS Survival Analysis of ICI associated Myocarditis NCT07633587 — registries, mortality, survival analysis, immune checkpoint inhibitors, myocarditis, myotoxicity, risk factors | N/A | Recruiting | 2026 |
| AI powered ECG Analysis for Deadly Arrhythmias and ICI Myocarditis NCT07644715 — arrhythmias, cardiac, immune checkpoint inhibitors, myocarditis, deep learning, learning, artificial intelligence, long qt syndrome, electrocardiography | N/A | Recruiting | 2026 |
| Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect a Prospective National Cohort NCT06762002 — cytokines, cells, autoantibodies, whole genome sequencing, phlebotomy, hospitalization, blood, vaccines, antibodies, immunophenotyping, hypersensitivity, neoplasms, thyroid gland, genome, vaccination, covid-19, immune system diseases, immunity, interferon type i, cell count, diagnosis, blood cells, exome, rheumatoid factor, history, communicable diseases, consent forms, genetic diseases, inborn, infections, blood cell count, plasma, virus diseases, allergy, immunology | N/A | Recruiting | 2025 |
| Genetic Determinants of Myocarditis Induced by Immune checkpoint Inhibitors NCT06734689 — cells, pharmaceutical preparations, immune checkpoint inhibitors, myocarditis, myositis | N/A | Recruiting | 2025 |
| Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias NCT05829993 — research design, intelligence, heart diseases, pharmaceutical preparations, heart rate, heart, arrhythmias, cardiac, algorithms, artificial intelligence, electrocardiography | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map